Clinical trial
Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle…
NCT00288951 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00288951 |
|---|---|
| Title | Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Open-angle Glaucoma, Ocular Hypertension |
| Intervention type | Drug |
| Interventions | Travoprost 0.004% with and without BAK |
| Enrollment | 690 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Feb 9, 2006 |
| Last update posted | Aug 17, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: